Full text is available at the source.
Abstract
The SPC-CRISPR system achieved a detection limit of 10 particles/μL for breast cancer exosomal proteins.
- The system converts protein signals on exosomes into nucleic acid signals through a split proximity circuit.
- Detection of phosphatidylserine, MUC1, and EpCAM on exosomes is facilitated by Tim4-modified magnetic beads and dual-aptamers.
- In clinical tests, the system distinguished breast cancer patients from healthy donors with an area under the curve (AUC) of 0.9778 and an accuracy of 91.23%.
- The system successfully detected stage 0 breast cancer with an accuracy of 92.59%.
- It differentiated metastatic from non-metastatic cases with statistical significance (p < 0.001).
- The method requires only 1 μL of serum and does not necessitate exosome isolation.
Simplified